drugset / Trial / NCT01156025
Efficacy and Safety of GV 550 in Acute Adenovirus Keratoconjunctivitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The study objective is to evaluate the efficacy and the safety of GV 550 in comparison to placebo in patients with acute adenoviral keratoconjuncivitis.
Timeline
- Start
- 2009-03
- Primary completion
- 2010-02
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ganciclovir | Small molecule | 1.5 unknown | Other |
| Background | Hyabak | Unknown | — | Other |